Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Athersys Company Profile

17:18 EDT 30th July 2014 | BioPortfolio

Athersys is a biopharmaceutical company engaged in the development and commercialization of therapeutic products that treat significant and life-threatening diseases.
As represented by its name, (Athersys - derived from advanced therapeutic systems), the Company is committed to developing novel therapeutic products that deliver substantial improvements over existing therapies through the application and utilization of its advanced, proprietary technology platforms.

Through internal development and acquisition of key technologies, Athersys has established a unique blend of competencies in areas such as molecular biology, cell biology, genomics, protein biochemistry, medicinal chemistry, and pharmacology. The Company has fully integrated pre-clinical drug discovery and development capabilities, and is focused on advancing a portfolio of therapeutic development programs into the clinic.

Location

3201 Carnegie Avenue
Cleveland
Ohio
44115-2634
United States of America

Contact

Phone: 216-431-9900
Fax: 216-361-9495
Email: jobs@athersys.com., ir@athersys.com


News Articles [32 Associated News Articles listed on BioPortfolio]

Stem cell company Athersys eyes potential new opportunities for its stroke therapy in Japan

Athersys (NYSE:ATHX) is looking to Japan for potential opportunities to bring its MultiStem therapies to market quicker. In its annual financial results call on Thursday, Athersys’ chief operati...

Recent Developments Do Not Justify Athersys' Doubling Since December

ByLouis Dematteis:Since early December, Athersys, Inc. (ATHX) is up more than 100%, with the company doubling in value from a little over $120M to its current capitalization of $240M. In an effort to...

Athersys: Two Crucial Near-Term Events

By JDT Investments:Athersys (ATHX) is a clinical stage biotech company focused primarily on its proprietary "Off-the-Shelf" stem cell product called Multistem. In a previous article I took a comprehen...

CT Catapult to work with Athersys to advance European development of MultiStem therapy

The Cell Therapy Catapult, which is focused on the development of the UK cell therapy industry to increase the nation's health and wealth, says it is working with US stem-cell specialist Athersys on m...

Athersys nets $19.1mm via RDO

Athersys Inc. (uses regenerative medicine to treat various conditions) netted $19.1mm through the sale of 5mm common shares at $4.10 each (a 38% premium) to returning shareholders. The company also is...

Athersys: Down But Not Out - An Interview With CEO Van Bokkelen

By Wall Street Titan:On April 28, 2014 Athersys (ATHX) reported the preliminary results of its Phase II Clinical Trial in Ulcerative Colitis. The double blinded, placebo controlled study is being fina...

Athersys' CEO Discusses Q4 2013 Results - Earnings Call Transcript

Athersys, Inc. (ATHX) Q4 2013 Results Earnings Conference Call March 13, 2013, 04:30 PM ET Executives Lisa Wilson - In-Site Communications, Investor Relations Laura Campbell - Vice President of Fi...

Athersys' (ATHX) CEO Gil Van Bokkelen on Q1 2014 Results - Earnings Call Transcript

Call Start: 16:30 Call End: 17:32 Athersys, Inc. (ATHX) Q1 2014 Earnings Conference Call May 8, 2014 4:30 PM ET Executives Amy Raskopf - IR B.J. Lehmann - President and COO Gil Van Bokkelen - Chai...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Athersys

Athersys is a biopharmaceutical company engaged in the development and commercialization of therapeutic products that treat significant and life-threatening diseases.As represented by its name, (Ather...

Athersys Incorporated

Athersys is a biotechnology company engaged in the research and development of products for the treatment and diagnosis of genetic and immunologic disorders. The company has a core expertise in the f...

Athersys, Inc.

Athersys is a clinical stage biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company...

More Information about "Athersys" on BioPortfolio

We have published hundreds of Athersys news stories on BioPortfolio along with dozens of Athersys Clinical Trials and PubMed Articles about Athersys for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Athersys Companies in our database. You can also find out about relevant Athersys Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record